Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

INTRODUCTION: Forced vital capacity is the only registrational endpoint in idiopathic pulmonary fibrosis clinical trials. As most new treatments will be administered on top of standard of care, estimating treatment response will become more challenging. We developed a simulation model to quantify va...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther
主要な著者: Santermans, Eva, Ford, Paul, Kreuter, Michael, Verbruggen, Nadia, Meyvisch, Paul, Wuyts, Wim A., Brown, Kevin K., Lederer, David J., Byrne, Adam J., Molyneaux, Philip L., Sivananthan, Arunon, Moor, Catharina C., Maher, Toby M., Wijsenbeek, Marlies
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2019
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822798/
https://ncbi.nlm.nih.gov/pubmed/31565781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01093-3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料